

Please try another search
By Gina Lee
Investing.com – Beigene Ltd. has received approval for an IPO on the Shanghai Stock Exchange’s Science and Technology Innovation Board, or STAR market, estimated to be worth around $3 billion.
The listing on the Chinese board would add to the company’s listings in the U.S. and Hong Kong, with a successful listing making Beigene the first biotech company to be listed in all three markets.
The STAR Market’s listing committee said that the proposed IPO met the market’s conditions and requirements for information disclosure, but stopped short of providing a timetable for the next steps. However, it added that Beigene will need to provide a further explanation on how it will adapt to the Chinese A-share market as well as how it will protect Chinese shareholders.
Beigene raised $182 million in Nasdaq in 2016 and $902 million in Hong Kong two years later.
The company’s Hong Kong shares (HK:6160) slid 2.75% to HK$ 205.40 ($26.45) at 11:18 PM ET (3:18 GMT), despite gaining more than 19% so far in 2021. Meanwhile, its U.S. shares (NASDAQ:BGNE) rose 1.88% to $349.65, and are up more than 31% in 2021.
China’s National Drug Reimbursement List, released in December 20202, included three Beigene drugs, including its Bruton's tyrosine kinase inhibitor Brukinsa.
By Elizabeth Dilts Marshall NEW YORK (Reuters) - World shares rose on Thursday and the U.S. dollar edged lower, a day after minutes from the U.S. Federal Reserve's May meeting...
By Chavi Mehta and Krystal Hu (Reuters) -Broadcom Inc said on Thursday it will acquire cloud computing company VMware (NYSE:VMW) Inc in a $61 billion cash-and stock deal, the...
By Davit Kirakosyan Dell Technologies (NYSE:DELL) shares rose more than 5% after-hours following the company’s Q1 results, with EPS of $1.84 coming in better than the Street...
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review
Add a Comment
We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:
Enrich the conversation, don’t trash it.
Stay focused and on track. Only post material that’s relevant to the topic being discussed.
Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.
Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.